Novo Nordisk and Eli Lilly Battle for GLP-1 Pill Market as Medicare Coverage Looms
The pharmaceutical giants are positioning their weight-loss medications for broader senior access as they prepare to compete for lucrative Medicare coverage decisions.
Read the full reporting at CNBC Markets.
Originally reported by CNBC Markets.